Medical Examination and Clinical Diagnosis

Risk factors for postoperative recurrence in patients with chronic sinusitis and nasal polyps treated by endoscopic sinus surgery

  • Dehong LI ,
  • Maomei NI ,
  • Ting CAI ,
  • Juanjuan REN
Expand
  • Department of Otorhinolaryngology Head and Neck Surgery,Guizhou Provincial People's Hospital,Guiyang 550002,Guizhou,China

Received date: 2025-06-24

  Online published: 2025-09-25

Abstract

Objective To analyze the risk factors for postoperative recurrence in patients with chronic sinusitis and nasal polyps (CRSwNP) treated by endoscopic sinus surgery ESS), and to construct a predictive model. Methods A retrospective study was conducted on 203 patients with CRSwNP who underwent ESS in the hospital from March 2022 to February 2023. These patients were divided into a recurrence group (n = 43) and an non-recurrence group (n = 160) based on whether they experienced recurrence after surgery. Clinical data were collected and analyzed using univariate analysis to identify significant differences. Lasso regression was used to screen potential influencing factors. Multivariate logistic regression was employed to analyze the risk factors. A nomogram was constructed for postoperative recurrence model, and the receiver operating characteristic (ROC) curve and calibration curve were used to evaluate the model. Results Single-factor analysis showed that disease duration, Lund-Mackay CT score, SNOT-22 score, EOS, ECP, total IgE, CRP, IL-5, and IL-1β in the recurrence group after ESS were higher than those in the non-recurrence group (P < 0.05), while the UPSIT score, CD3+, CD4+, CD8+, and CD4+/CD8+ were lower (P < 0.05); the proportion of patients with allergic rhinitis, asthma, no preoperative glucocorticoid treatment, and surgery time ≥ 2 hours in the recurrence group after ESS was higher than that in the non-recurrence group (P < 0.05). Multivariate logistic regression analysis model showed that disease duration (OR = 1.389, 95% CI: 1.094 ~ 1.763, P = 0.007), combined asthma (OR = 2.997, 95% CI: 1.065 ~ 8.432, P = 0.038), Lund-Mackay CT score (OR = 1.156, 95% CI: 1.027 ~ 1.301, P = 0.016), EOS (OR = 1.540, 95% CI: 1.249 ~ 1.898, P < 0.001), total IgE (OR = 1.005, 95% CI: 1.000 ~ 1.009, P = 0.041), and IL-5 (OR = 1.165, 95% CI: 1.078 ~ 1.260, P < 0.001) were risk factors for ESS recurrence. Based on multivariate logistic regression analysis nomogram, the area under the ROC curve (AUC) was 0.9057; the sensitivity 76.74%; the specificity 87.5%; the average absolute error (MAE) of the calibration curve 0.03; the mean square error (MSE) 0.00157, and the absolute error at the 0.9 percentile 0.065. Conclusions Disease course, the presence of asthma, Lund-Mackay CT score, EOS, total IgE, and IL-5 are all risk factors for postoperative recurrence in patients with CRSwNP. Moreover, the relevant nomogram model can be used as a reliable tool for assessing the risk of postoperative recurrence in CRSwNP.

Cite this article

Dehong LI , Maomei NI , Ting CAI , Juanjuan REN . Risk factors for postoperative recurrence in patients with chronic sinusitis and nasal polyps treated by endoscopic sinus surgery[J]. The Journal of Practical Medicine, 2025 , 41(18) : 2928 -2936 . DOI: 10.3969/j.issn.1006-5725.2025.18.021

References

[1] GEVAERT P, DESROSIERS M, CORNET M, et al. Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): Phase 3, randomised, double-blind, parallel trials[J]. Lancet, 2025, 405(10482): 911-926. doi:10.1016/s0140-6736(25)00197-7
[2] DORLING M, HERNAIZ-LEONARDO J C, PASCUAL A, et al. Real-world adverse events after type 2 biologic use in chronic rhinosinusitis with nasal polyps[J]. Laryngoscope, 2024, 134(7): 1-12. doi:10.1002/lary.31305
[3] XU Y, TONG X, LIU P, et al. Deficiency of INPP4A promotes M2 macrophage polarization in eosinophilic chronic rhinosinusitis with nasal polyps[J]. Inflamm Res, 2024, 73(4): 501-515. doi:10.1007/s00011-024-01855-y
[4] 李德宏,倪茂美,任娟娟,等. 鼻窦药物支架在复发性鼻窦炎中的短期疗效[J]. 实用医学杂志, 2023, 39(3):315-320.
[5] HELLINGS P W, ALOBID I, ANSELMO-LIMA W T, et al. EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care[J]. Allergy, 2024, 79(5): 1234-1248. doi:10.1111/all.15982
[6] 杨玉成, 张玥. 慢性鼻窦炎伴鼻息肉的整体评估与个体化精准治疗[J]. 中华耳鼻咽喉头颈外科杂志, 2022, 57(2): 217-221.
[7] HEFFLER E M, LAIDLAW T M, FUJIEDA S, et al. Baseline characteristics of patients with chronic rhinosinusitis with nasal polyps and coexisting asthma initiating dupilumab in the AROMA global registry[J]. Eur Respir J, 2024, 64(Sup68): 4251-4254.
[8] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组,中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 中国慢性鼻窦炎诊断和治疗指南(2018)[J]. 中华耳鼻咽喉头颈外科杂志,2019,54(2):81-100. doi:10.3760/cma.j.issn.1673-0860.2019.02.001
[9] LIU C M. In response to predictors of sinonasal improvement after highly effective modulator therapy in adults with cystic fibrosis[J]. Laryngoscope, 2024, 134(12): 2673-2675. doi:10.1002/lary.31598
[10] OFFERLE T L, BORISH L. Sino-Nasal Outcome Test-22[J]. Ann Allergy Asthma Immunol, 2025, 134(3): 257-258. doi:10.1016/j.anai.2024.12.007
[11] MAHADEV A, KALLOGJERI D, PICCIRILLO J F. Validation of minimal clinically important difference (MCID) for University of Pennsylvania Smell Identification Test (UPSIT)[J]. Am J Rhinol Allergy, 2024, 38(2): 85-92. doi:10.1177/19458924231218037
[12] ALTAMIRANO C D, BREIDENBAUGH M, BORISH L. Don't lose sleep over chronic rhinosinusitis with nasal polyps[J]. Ann Allergy Asthma Immunol, 2024, 132(1): 5-6. doi:10.1016/j.anai.2023.09.012
[13] 汪文华,王广科,武天义,等. 根治性鼻内镜手术治疗嗜酸粒细胞增高型慢性鼻窦炎伴鼻息肉的疗效分析 [J]. 临床耳鼻咽喉头颈外科杂志, 2023, 37 (1): 20-24.
[14] RONGFENG MA M M. Clinical Control and Quality of Life in Patients With Chronic Rhinosinusitis With Asthma: A Study on the Effects of Endoscopic Sinus Surgery[J]. Otolaryngol Head Neck Surg, 2025, 172(1): 313-320. doi:10.1002/ohn.1040
[15] JIANG S, ZHANG C, TONG Z, et al. Soluble guanylate cyclase dysfunction and nitric oxide pathway in chronic rhinosinusitis with nasal polyps: Predictive markers for postoperative recurrence[J]. Am J Rhinol Allergy, 2025, 39(1): 45-52. doi:10.1177/19458924241289645
[16] GAO R, CHEN Y, LIU H, et al. CD109 identified in circulating proteomics mitigates postoperative recurrence in chronic rhinosinusitis with nasal polyps by suppressing TGF-β1-induced epithelial-mesenchymal transition[J]. Int Immunopharmacol, 2024, 130: 111793. doi:10.1016/j.intimp.2024.111793
[17] 蒋思洁, 谢邵兵, 章华, 等. 基于机器学习对慢性鼻窦炎伴鼻息肉预后模型的初探[J]. 中华耳鼻咽喉头颈外科杂志, 2024, 59(6): 543-550.
[18] 冯娟娟,程泽星,肖路. NLRP3炎性小体水平联合ECP/MPO比值预测慢性鼻窦炎鼻内镜术后复发的临床价值[J]. 实用医学杂志, 2024, 40(22): 3196-3201.
[19] SIMPSON T, TALATI V, BAIRD A M, et al. Histopathology of allergic fungal rhinosinusitis versus chronic rhinosinusitis with nasal polyps[J]. Laryngoscope, 2024, 134(6): 1234-1245. doi:10.1002/lary.31225
[20] SOHAIL A, CHO L, HACKER J, et al. Human nasal epithelial cells express IL-5Rα but not the co-receptor CSF2RB and do not signal to IL-5[J]. Allergy, 2024, 79(11): 2345-2356. doi:10.1111/all.16218
[21] ZHANG Q, ZHANG C, CHEN J, et al. Correlation between Lund-Mackay computed tomography score and subjective symptoms in Chinese patients with nasal polyps[J]. Acta Otolaryngol, 2025, 145(1/2): 56-65. doi:10.1080/00016489.2024.2412720
[22] 刘承耀, 王向东, 司马宇彤, 等. 嗜酸粒细胞性鼻窦炎伴鼻息肉患者术后症状及体征变化在预测复发中的作用[J]. 临床耳鼻咽喉头颈外科杂志, 2023, 37(11): 864-870.
[23] GATA A, LEUCUTA D C, BUDISAN L, et al. MicroRNA-125b is a potential predictor of surgical outcomes in chronic rhinosinusitis with nasal polyps[J]. Am J Rhinol Allergy, 2024, 38(2): 93-100. doi:10.1177/19458924231224343
[24] MS P H D. A pathogenic role for innate-like B cells in type 2 chronic rhinosinusitis with nasal polyps: A novel IgE-producing population[J]. Ann Allergy Asthma Immunol, 2024, 132(2): 156-165. doi:10.1016/j.anai.2023.11.007
[25] SIMPSON T, TALATI V, BAIRD A M, et al. Histopathology of allergic fungal rhinosinusitis versus chronic rhinosinusitis with nasal polyps[J]. Laryngoscope, 2024, 134(6): 1234-1245. doi:10.1002/lary.31225
[26] PALOMARES I, LOUKIDES S, SCHLEICH F, et al. Real-world effectiveness of mepolizumab in patients with severe asthma with/without chronic rhinosinusitis with nasal polyps: Pooled analysis from European cohorts[J]. Eur Respir J, 2024, 64(Sup68): PA3929.
[27] 王明, 洪宇, 卜祥婷, 等. 慢性鼻窦炎伴鼻息肉鼻黏膜中纤维蛋白交联和降解相关调控基因表达异常[J]. 首都医科大学学报, 2024, 45(2): 246-251.
Outlines

/